WHO Model Prescribing Information: Drugs Used in Skin Diseases
(1997; 132 pages) [French] [Spanish] Ver el documento en el formato PDF
Índice de contenido
Ver el documentoPreface
Ver el documentoIntroduction
Abrir esta carpeta y ver su contenidoParasitic infections
Abrir esta carpeta y ver su contenidoInsect and arachnid bites and stings
Abrir esta carpeta y ver su contenidoSuperficial fungal infections
Abrir esta carpeta y ver su contenidoSubcutaneous fungal infections
Abrir esta carpeta y ver su contenidoBacterial infections
Abrir esta carpeta y ver su contenidoViral infections
Abrir esta carpeta y ver su contenidoEczematous diseases
Abrir esta carpeta y ver su contenidoScaling diseases
Abrir esta carpeta y ver su contenidoPapulosquamous diseases
Ver el documentoCutaneous reactions to drugs
Abrir esta carpeta y ver su contenidoPigmentary disorders
Abrir esta carpeta y ver su contenidoPremalignant lesions and malignant tumours
Cerrar esta carpetaPhotodermatoses
Ver el documentoSolar urticaria
Ver el documentoPolymorphous light eruptions
Ver el documentoActinic prurigo
Ver el documentoChemical photodermatoses
Abrir esta carpeta y ver su contenidoBullous dermatoses
Ver el documentoAlopecia areata
Ver el documentoUrticaria
Abrir esta carpeta y ver su contenidoConditions common in children
Ver el documentoAcne vulgaris
Ver el documentoPruritus
Ver el documentoTropical ulcers
Abrir esta carpeta y ver su contenidoAntimicrobial drugs
Abrir esta carpeta y ver su contenidoAntifugal drugs
Abrir esta carpeta y ver su contenidoAntiseptic agents
Abrir esta carpeta y ver su contenidoKeratoplastic and keratolytic agents
Abrir esta carpeta y ver su contenidoScabicides and pediculicides
Abrir esta carpeta y ver su contenidoAnti-inflammatory and antipruritic drugs1
Abrir esta carpeta y ver su contenidoAntiallergics and drugs used in anaphylaxis
Abrir esta carpeta y ver su contenidoUltraviolet radiation-blocking agents (sunscreens)
Abrir esta carpeta y ver su contenidoMiscellaneous drugs
Abrir esta carpeta y ver su contenidoAnnex
Ver el documentoSelected WHO Publications of Related Interest
Ver el documentoBack cover
 

Chemical photodermatoses

Chemical photodermatoses are either phototoxic or photo-allergic reactions. Phototoxic reactions, which are more common, result from topical or systemic exposure to photosensitizing agents that are activated by exposure to sunlight or other sources of ultraviolet radiation. They are characterized by sunburn-like erythema, sometimes with oedema restricted to the light-exposed areas. Photoallergic reactions result from sensitization to a systemically or topically administered allergen. Demeclocycline, which is used for the treatment of resistant acne vulgaris, is a frequent cause of photosensitivity reactions and patients using it must be warned about the risks of exposure to ultraviolet light. Other photosensitizing agents include sulfonamides, salicylanilides, non-steroidal anti-inflammatory agents, phenothiazines, tar products, dyes, plant constituents (including psoralens), fragrances, animal feedstuffs, and topical sunscreens.

Treatment

Symptomatic treatment with systemic antihistamines and acetylsalicylic acid can alleviate discomfort, pruritus and erythema.

Prevention depends upon avoidance of contact with presumed causative agents.

 

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 24 abril 2012